| The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions MR Khezri, R Jafari, K Yousefi, NM Zolbanin Experimental and molecular pathology 127, 104787, 2022 | 48 | 2022 |
| The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy MR Khezri, R Varzandeh, M Ghasemnejad-Berenji Cellular & Molecular Biology Letters 27 (1), 6, 2022 | 41 | 2022 |
| PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19 MR Khezri Human Cell 34 (2), 700-701, 2021 | 41 | 2021 |
| Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection MR Khezri, NM Zolbanin, M Ghasemnejad-Berenji, R Jafari European journal of pharmacology 905, 174191, 2021 | 40 | 2021 |
| The role of ERK1/2 pathway in the pathophysiology of Alzheimer’s disease: an overview and update on new developments MR Khezri, K Yousefi, A Esmaeili, M Ghasemnejad-Berenji Cellular and molecular neurobiology 43 (1), 177-191, 2023 | 28 | 2023 |
| Metformin in Alzheimer’s disease: An overview of potential mechanisms, preclinical and clinical findings MR Khezri, K Yousefi, N Mahboubi, D Hodaei, M Ghasemnejad-Berenji Biochemical pharmacology 197, 114945, 2022 | 25 | 2022 |
| Gastroprotective effect of topiramate on indomethacin‐induced peptic ulcer in rats: Biochemical and histological analyses A Jafari, N Andishfar, Z Esmaeilzadeh, MR Khezri, ... Basic & Clinical Pharmacology & Toxicology 130 (5), 559-568, 2022 | 22 | 2022 |
| Icariin: A potential neuroprotective agent in Alzheimer’s disease and Parkinson’s disease MR Khezri, M Ghasemnejad-Berenji Neurochemical Research 47 (10), 2954-2962, 2022 | 20 | 2022 |
| Protective effects of metformin against aluminum phosphide-induced acute hepato-renal damage in rats: an experimental approach MR Khezri, R Varzandeh, M Ghasemnejad-Berenji Pesticide Biochemistry and Physiology 188, 105258, 2022 | 12 | 2022 |
| Anticancer potential of metformin: focusing on gastrointestinal cancers M Khezri, H Malekinejad, N Majidi-Zolbanin, M Ghasemnejad-Berenji Cancer Chemotherapy and Pharmacology 87 (5), 587-598, 2021 | 11 | 2021 |
| MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview MR Khezri, K Yousefi, NM Zolbanin, M Ghasemnejad-Berenji Molecular Neurobiology, 1-15, 2022 | 10 | 2022 |
| Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence MR Khezri, M Mohebalizadeh, M Ghasemnejad-Berenji Cell Communication and Signaling 21 (1), 60, 2023 | 9 | 2023 |
| An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS‐CoV‐2 infection: A hypothesis A Jafari, Z Esmaeilzadeh, MR Khezri, H Ghasemnejad‐Berenji, ... Journal of Food Biochemistry 46 (10), e14345, 2022 | 9 | 2022 |
| The promising effect of topiramate on random-pattern skin flap survival in rats M Ahmadzadeh, Z Esmaeilzadeh, MR Khezri, A Jafari, ... Aesthetic Plastic Surgery 46 (5), 2548-2555, 2022 | 7 | 2022 |
| Hesperetin and the PI3K/AKT pathway: Could their interaction play a role in the entry and replication of the SARS‐CoV‐2? MR Khezri, M Ghasemnejad‐Berenji, D Moloodsouri Journal of Food Biochemistry 46 (9), e14212, 2022 | 5 | 2022 |
| Neurological effects of elevated levels of angiotensin II in COVID-19 patients MR Khezri, M Ghasemnejad-Berenji Human Cell 34 (6), 1941-1942, 2021 | 5 | 2021 |
| Angiotensin II: a possible target for therapeutic intervention in COVID-19 MR Khezri, K Yousefi, M Ghasemnejad-Berenji Biomedicine & pharmacotherapy= Biomedecine & pharmacotherapie 139, 111564, 2021 | 5 | 2021 |
| The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer’s Disease: Which One Is the Beginner? MR Khezri, M Ghasemnejad-Berenji, D Moloodsouri Journal of Alzheimer's Disease 92 (2), 391-393, 2023 | 4 | 2023 |
| Potential effects of icariin, the Epimedium-derived bioactive compound in the treatment of COVID‐19: a hypothesis MR Khezri, F Nazari-Khanamiri, T Mohammadi, D Moloodsouri, ... Naunyn-Schmiedeberg's archives of pharmacology 395 (9), 1019-1027, 2022 | 4 | 2022 |
| Therapeutic potential of loureirin A against SARS‐CoV‐2 infection MR Khezri, D Moloodsouri, D Hodaei, M Ghasemnejad‐Berenji Phytotherapy Research 36 (8), 3011, 2022 | 4 | 2022 |
Morteza Ghasemnejad-BerenjiAssistant Professor of Pharmacology, Urmia University of Medical SciencesVerified email at umsu.ac.ir
